Show results for
Refine by
Drugs For The Treatment Services Available In Lithuania
15 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Any malfunction of key enzymes (mutation, overproduction, underproduction or deletion) can lead to diseases. Therefore, enzymes have long been considered as important drug targets for the treatment of major human ...
by:IMARC Group based inNoida, INDIA
Market/Product assessment reports give our clients a deep insight into the dynamics of the Industry. These studies serve as an analytical as well as a statistical tool to understand the regulations, trends, market structure, sales, supply chain, competitive landscape, drivers, restraints and the outlook of the Industry. Our market research reports serve as an excellent guide for investors, ...
Manufactured by:Fab’entech based inLyon, FRANCE
Due to their immediate neutralising action, Fab’entech’s polyclonal antibodies can be used to design therapies that are well suited to the management and treatment of drug ...
by:3D-Shaper Medical SL based inBarcelona, SPAIN
Whether you are a small or a large pharmaceutical company, a CRO, an academic institution or a research center, you can benefit from our 3D-SHAPER® data analysis service of bone densitometry (DXA) scans. Our service uses 3D-Shaper Technology. It allows you to analyze in 3D the effects of drug treatments on the cortical and trabecular bone from bone ...
by:Italfarmaco SpA based inMilan, ITALY
The Pharmacovigilance system collects and studies adverse events (=noxious) which may be associated to a drug treatment, in order to assess their incidence. identify the cause-effect relationship with the use of the drug. identify any possible risk factors for the occurrence of such adverse events. identify possible means for the prevention of ...
Manufactured by:MediTECH Electronic GmbH based inWedemark, GERMANY
The decision on whether a person has ADHD/ADHD has so far been based mainly on questionnaires and behavioural observation. Both methods are highly subjective. In cooperation with the Charité Berlin and the University Clinic Mainz, MediTECH has developed a new objective measurement procedure for the determination / exclusion of ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
Manufactured by:MODAG GmbH based inWendelsheim, GERMANY
Multiple System Atrophy (MSA) is a rare neurodegenerative disorder that belongs to the group of synucleinopathies and is also classified as an “atypical parkinsonism” disorder. Pathologically, MSA is characterized by abnormal deposits of the α-synuclein protein mainly in oligodendroglial cells and also in certain nerve cells. Typically, there is a dysfunction of the autonomic ...
Manufactured by:CDBioSciences - VLPlant based inShirley, NEW YORK (USA)
cVLPs are formed from VLPs and ligands through genetic fusion or chemical conjugation. As a leading global provider of custom services, CD BioSciences has advanced facilities and experienced scientists dedicated to cVLPs development services to help our customers develop vaccines, nanomaterials and diagnostic ...
by:OracleBio based inGlasgow, UNITED KINGDOM
Fast turnaround, accurate data; enabling you to move forward with confidence. Quantitative Digital Pathology provides detailed cell by cell data to enhance decision making in NASH & Fibrosis research. Our dedicated team of image analysis scientists have extensive experience in the accurate quantification of fibrosis, steatosis and inflammation. ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
Work on earlier programmes investigating infections in areas such as respiratory, dermal, ocular and biofilms carries on as research projects, including academic and/or commercial collaborations and grant funded ...
by:elminda Ltd. based inHerzliya, ISRAEL
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease heterogeneity. BNA may contribute in CNS research and drug development by adding new objective endpoints, assisting in ...
Manufactured by:Neuron Bio based inGranada, SPAIN
Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops tools and biomarkers for ...
by:OracleBio based inGlasgow, UNITED KINGDOM
At OracleBio, we have extensive experience in providing pre-clinical services to support clients in the early stages of the drug discovery pipeline. We understand that our clients need their data quickly, so we work hard to ensure a fast turnaround time, with a team of dedicated image analysis scientists and high-powered computing servers for fast image processing. ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Profiling the Tumor Microenvironment: Using a genomics based approach to analyze the tumor microenvironment can provide unique insights beyond IHC and FACS methods. OncoPeptTUME deeply interrogates RNA-Seq data sets to produce high resolution mapping of the tumor microenvironment using proprietary cell type specific gene expression signatures. OncoPeptTUME provides a critical assessment of the ...